What is PTC Therapeutics's common stock?

PTC Therapeutics (PTCT) reported common stock of $81K in Q1 2026.

How has PTC Therapeutics's common stock changed year-over-year?

PTC Therapeutics's common stock increased by 3.8% year-over-year, from $78K to $81K.

What is the long-term trend for PTC Therapeutics's common stock?

Over 5 years (2020 to 2025), PTC Therapeutics's common stock has grown at a 2.7% compound annual growth rate (CAGR), from $70K to $80K.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

PTC Therapeutics PTCT Common Stock

Common Stock at other companies

BioMarin PharmaceuticalsBMRN

500M0.0%

BridgeBio PharmaBBIO

500M+253,707%

Arrowhead ResearchARWR

$236K+2.6%

United TherapeuticsUTHR

$800K0.0%

BiogenBIIB

$100K0.0%

ALN

Alnylam PharmaceuticalsALNY

——

Other financials

Income statement

See full

Revenue$272.6M-76.8%

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

See full

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

See full

Operating cash flow-$59.0M-107%

CapEx$1.2M-30.6%

Free cash flow-$60.2M-107%

Valuation

See full

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/E8×—

P/S7.9×+5.3×

Profitability

See full

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

See full

Return on equity-216.7%—

Debt / equity372.3×—

Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTC Therapeutics's common stock?: PTC Therapeutics (PTCT) reported common stock of $81K in Q1 2026.
How has PTC Therapeutics's common stock changed year-over-year?: PTC Therapeutics's common stock increased by 3.8% year-over-year, from $78K to $81K.
What is the long-term trend for PTC Therapeutics's common stock?: Over 5 years (2020 to 2025), PTC Therapeutics's common stock has grown at a 2.7% compound annual growth rate (CAGR), from $70K to $80K.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).